Skip to content

Furosemide Impurity 3

Furosemide Impurity 3

Product Description
CAT No.
ALN-F032011
CAS No.
NA
Mol. F.
C19H16N2O6S
Mol. Wt.
400.4
Stock
Please Inquire
RFQ
Chemical Name : N-(Furan-2-ylmethyl)-8-hydroxyanthracene-1-sulfonamide nitrite
Smiles : O=S(C1=CC=CC2=CC3=CC=CC(O)=C3C=C12)(NCC4=CC=CO4)=O.O=NO
Inchi : InChI=1S/C15H9ClO5S/c16-13-5-4-9(15(17)18)11-6-8-2-1-3-14(22(19,20)21)10(8)7-12(11)13/h1-7H,(H,17,18)(H,19,20,21)

A New Way of Stabilization of Furosemide upon Cryogenic Grinding by Using Acylated Saccharides Matrices. The Role of Hydrogen Bonds in Decomposition Mechanism

E. Kaminska,*,u2020 K. Adrjanowicz,u2021,u00a7 K. Kaminski,u00a7,u2225 P. Wlodarczyk,u22a5 L. Hawelek,u00a7,u22a5 K. Kolodziejczyk,u00a7 M. Tarnacka,u00a7 D. Zakowiecki,# I. Kaczmarczyk-Sedlak,u2020 J. Pilch,u2207 and M. PaluchnMol. Pharmaceutics 2013, 10, 5, 1824u20131835

Effect of Cryogrinding on Chemical Stability of the Sparingly Water-Soluble Drug Furosemide

,† K. Adrjanowicz,‡,§ K. Kaminski,§,∥ P. Wlodarczyk,⊥ L. Hawelek,§,⊥ K. Kolodziejczyk,§ M. Tarnacka,§ D. Zakowiecki,# I. Kaczmarczyk-Sedlak,† J. Pilch,∇ and M. Paluch – Mol. Pharmaceutics 2013, 10, 5, 1824–1835

Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide

Karolina Adrjanowicz, Kamil Kaminski, Katarzyna Grzybowska, Lukasz Hawelek, Marian Paluch, Irena Gruszka, Daniel Zakowiecki, Wieslaw Sawicki, Przemyslaw Lepek, Wojciech Kamysz & Lukasz Guzik – Pharmaceutical Research volume 28, pages3220–3236(2011)

Request For Quotation

Related Products